China

China invented Medicines for Alzheimer’s, First Major Research after 17 Years

Monali Gupta

China has approved a drug to fight Alzheimer's disease. This medicine is made by the company of Shanghai, which is ready for the first time in itself. This medicine will be started for the common people from next month. In the last seventeen years, the first major research has been done in this field.

China's National Medical Product Administration, in its statement, approved the introduction of this drug named 'Oligomannet' in the market. During the trial, this medicine started showing effect on the patient within the first 4 weeks. This medicine has been made after nearly two decades of hard work.

According to local agencies, this medicine will be introduced in the market from December. Significantly, there is no medicine to fight Alzheimer's in the world right now, but China has shown such a feat.

Green Valley has said in its statement that initially it will be sold only locally, later it will also be made available in the countries of America, Asia and Europe.

Green Valley is one of the largest research companies in China, working in medical science. For the last several years China has been trying to make a big investment in medical science and produce some new medicines in its country.

Let us tell you that there are about 10 million people suffering from Alzheimer's in China, which is the highest figure in the world. While this number is more than 5 crore in the world. The company having this medicine checked this medicine on 818 patients during the trial.

The Wait is Over, Prabhas and Deepika's 'Kalki 2898 AD' Set to Make a Splash on This Day

Kejriwal in Jail, Wife Sunita Conducts First Roadshow in Delhi, Makes Emotional Appeal to Public

Chennai Super Kings Vs Sunrisers Hyderabad: When And Where To Watch 46th Match Of TATA IPL 2024?

Punjab: Khalistan Supporter Amritpal to Contest Lok Sabha Elections from Khadoor Sahib Seat, Currently Imprisoned in Assam Jail

BJP MP Brij Bhushan Singh Faces Setback as Court Rejects Petition Seeking Fresh Probe